Literature DB >> 19629241

Attention deficit hyperactivity disorder in adulthood: diagnosis, etiology and therapy.

Alexandra Philipsen1, Bernd Hesslinger, Ludger Tebartz van Elst.   

Abstract

INTRODUCTION: Until the late nineties, attention deficit and hyperactivity disorder (ADHD) was often regarded in Germany as a disorder that fades away in late adolescence. However, it has recently become clear from numerous studies that core symptoms of ADHD persist into adulthood in a substantial subgroup of patients.
METHODS: Selective review of relevant literature in Medline, up to September 2007.
RESULTS: The prevalence of ADHD in adulthood is estimated at about 2%. Core symptoms include attention deficit in the presence of understimulation, chronic restlessness, impulsivity, disorganized behaviour, and disorders of affect regulation. The extent of psychosocial impairment depends on symptom severity, psychiatric comorbidity (such as addiction or depression), and psychosocial support. As in childhood, ADHD in adulthood is a clinical diagnosis. Genetic factors probably play a key role in primary ADHD. Treatment should include psychotherapy and medical treatment. DISCUSSION: ADHD in adulthood is commoner than for example bipolar disorder or schizophrenia. It may be regarded as a risk factor for the development of other psychiatric conditions. Highly effective treatment is possible not only in childhood but also in adulthood. The problem of off-label use of psychotropic medication in adults limits treatment in adult ADHD.

Entities:  

Keywords:  ADHD; adulthood; diagnosis; methylphenidate; treatment

Year:  2008        PMID: 19629241      PMCID: PMC2696867          DOI: 10.3238/arztebl.2008.0311

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  24 in total

1.  Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.

Authors:  Lenard A Adler; Virginia K Sutton; Rodney J Moore; Anthony P Dietrich; Frederick W Reimherr; R Bart Sangal; Keith E Saylor; Kristina Secnik; Douglas K Kelsey; Albert J Allen
Journal:  J Clin Psychopharmacol       Date:  2006-12       Impact factor: 3.153

2.  A combined treatment approach for adults with ADHD--results of an open study of 43 patients.

Authors:  Anthony L Rostain; J Russell Ramsay
Journal:  J Atten Disord       Date:  2006-11       Impact factor: 3.256

Review 3.  Attention deficit/hyperactivity disorder across the lifespan.

Authors:  Timothy E Wilens; Joseph Biederman; Thomas J Spencer
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

4.  Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder -- a magnet resonance spectroscopy study.

Authors:  E Perlov; A Philipsen; B Hesslinger; M Buechert; J Ahrendts; B Feige; E Bubl; J Hennig; D Ebert; L Tebartz van Elst
Journal:  J Psychiatr Res       Date:  2007-02-15       Impact factor: 4.791

5.  A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder.

Authors:  Caroline S Stevenson; Stephanie Whitmont; Laurel Bornholt; David Livesey; Richard J Stevenson
Journal:  Aust N Z J Psychiatry       Date:  2002-10       Impact factor: 5.744

6.  Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study.

Authors:  Alexandra Philipsen; Harald Richter; Julia Peters; Barbara Alm; Esther Sobanski; Michael Colla; Mirka Münzebrock; Corinna Scheel; Christian Jacob; Evgeniy Perlov; Ludger Tebartz van Elst; Bernd Hesslinger
Journal:  J Nerv Ment Dis       Date:  2007-12       Impact factor: 2.254

7.  [Attention deficit hyperactivity disorder in adults. An overview].

Authors:  E Sobanski; B Alm
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

Review 8.  Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.

Authors:  Thomas J Spencer; Joseph Biederman; Eric Mick
Journal:  J Pediatr Psychol       Date:  2007-06-07

9.  Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity.

Authors:  J Biederman; S Milberger; S V Faraone; K Kiely; J Guite; E Mick; S Ablon; R Warburton; E Reed
Journal:  Arch Gen Psychiatry       Date:  1995-06

Review 10.  [Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].

Authors:  M Huber; E Kirchler; H Niederhofer; L Gruber
Journal:  Fortschr Neurol Psychiatr       Date:  2006-11-17       Impact factor: 0.752

View more
  5 in total

Review 1.  [Survey of attention deficit hyperactivity disorder in adults].

Authors:  W Hausotter
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214

2.  The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

Authors:  Ingrid Schubert; Ingrid Köster; Gerd Lehmkuhl
Journal:  Dtsch Arztebl Int       Date:  2010-09-10       Impact factor: 5.594

3.  Normal Neurochemistry in the Prefrontal and Cerebellar Brain of Adults with Attention-Deficit Hyperactivity Disorder.

Authors:  Dominique Endres; Evgeniy Perlov; Simon Maier; Bernd Feige; Kathrin Nickel; Peter Goll; Emanuel Bubl; Thomas Lange; Volkmar Glauche; Erika Graf; Dieter Ebert; Esther Sobanski; Alexandra Philipsen; Ludger Tebartz van Elst
Journal:  Front Behav Neurosci       Date:  2015-09-28       Impact factor: 3.558

4.  Mindfulness-Based Cognitive Therapy and the Adult ADHD Brain: A Neuropsychotherapeutic Perspective.

Authors:  Katharina Bachmann; Alexandra P Lam; Alexandra Philipsen
Journal:  Front Psychiatry       Date:  2016-06-27       Impact factor: 4.157

5.  Neurochemical sex differences in adult ADHD patients: an MRS study.

Authors:  Dominique Endres; Ludger Tebartz van Elst; Simon J Maier; Bernd Feige; Peter Goll; Simon A Meyer; Swantje Matthies; Katharina Domschke; Thomas Lange; Esther Sobanski; Alexandra Philipsen; Kathrin Nickel; Evgeniy Perlov
Journal:  Biol Sex Differ       Date:  2019-10-29       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.